MeiraGTx Holdings plc Operating Income
MeiraGTx Holdings plc (MGTX) reported Operating Income of $244.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- MeiraGTx Holdings plc operating income (loss) for the quarter ending 2026-06-30 was $244.43M.
- MeiraGTx Holdings plc operating income (loss) for the quarter ending 2026-03-31 was -$40.82M.
- MeiraGTx Holdings plc operating income (loss) for the quarter ending 2025-12-31 was $26.47M.
- MeiraGTx Holdings plc operating income (loss) for the quarter ending 2025-09-30 was -$46.05M.
- MeiraGTx Holdings plc operating income (loss) for fiscal 2025 was -$105.97M.
- MeiraGTx Holdings plc operating income (loss) for fiscal 2024 was -$164.21M.
- MeiraGTx Holdings plc operating income (loss) for fiscal 2023 was -$137.06M.
- MeiraGTx Holdings plc operating income (loss) for fiscal 2022 was -$116.36M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $244.43M 10-Q · filed 2026-08-13 | $203.61M 10-Q · filed 2026-08-13 | $230.08M derived: sum of 3 quarters · filed 2026-08-13 | $184.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$40.82M 10-Q · filed 2026-05-14 | -$14.35M derived: sum of 2 quarters · filed 2026-05-14 | -$60.40M derived: sum of 3 quarters · filed 2026-05-14 | -$105.19M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $26.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$19.58M derived: sum of 2 quarters · filed 2026-03-30 | -$64.37M derived: sum of 3 quarters · filed 2026-08-13 | -$105.97M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$46.05M 10-Q · filed 2025-11-13 | -$90.84M derived: sum of 2 quarters · filed 2026-08-13 | -$132.44M 10-Q · filed 2025-11-13 | -$163.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$44.79M 10-Q · filed 2026-08-13 | -$86.39M 10-Q · filed 2026-08-13 | -$117.88M derived: sum of 3 quarters · filed 2026-08-13 | -$157.92M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$41.60M 10-Q · filed 2026-05-14 | -$73.09M derived: sum of 2 quarters · filed 2026-05-14 | -$113.13M derived: sum of 3 quarters · filed 2026-05-14 | -$159.04M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$31.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$71.53M derived: sum of 2 quarters · filed 2026-03-30 | -$117.44M derived: sum of 3 quarters · filed 2026-03-30 | -$164.21M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$40.04M 10-Q · filed 2025-11-13 | -$85.95M derived: sum of 2 quarters · filed 2025-11-13 | -$132.72M 10-Q · filed 2025-11-13 | -$176.48M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$45.91M 10-Q · filed 2025-08-14 | -$92.68M 10-Q · filed 2025-08-14 | -$136.44M derived: sum of 3 quarters · filed 2025-08-14 | -$169.20M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$46.77M 10-Q · filed 2025-05-13 | -$90.53M derived: sum of 2 quarters · filed 2025-05-13 | -$123.29M derived: sum of 3 quarters · filed 2025-05-13 | -$152.07M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$43.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$76.52M derived: sum of 2 quarters · filed 2025-03-13 | -$105.30M derived: sum of 3 quarters · filed 2025-03-13 | -$137.06M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | -$32.76M 10-Q · filed 2024-11-13 | -$61.55M derived: sum of 2 quarters · filed 2024-11-13 | -$93.31M 10-Q · filed 2024-11-13 | -$134.36M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$28.79M 10-Q · filed 2024-08-12 | -$60.55M 10-Q · filed 2024-08-12 | -$101.60M derived: sum of 3 quarters · filed 2024-08-12 | -$124.41M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | -$31.76M 10-Q · filed 2024-05-09 | -$72.81M derived: sum of 2 quarters · filed 2024-05-09 | -$95.62M derived: sum of 3 quarters · filed 2024-05-09 | -$119.38M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$41.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$63.86M derived: sum of 2 quarters · filed 2024-03-15 | -$87.62M derived: sum of 3 quarters · filed 2024-03-15 | -$116.36M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$22.81M 10-Q · filed 2023-11-14 | -$46.57M derived: sum of 2 quarters · filed 2023-11-14 | -$75.30M 10-Q · filed 2023-11-14 | -$82.99M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$23.76M 10-Q · filed 2023-08-10 | -$52.49M 10-Q · filed 2023-08-10 | -$60.18M derived: sum of 3 quarters · filed 2023-08-10 | -$82.73M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$28.73M 10-Q · filed 2023-05-11 | -$36.42M derived: sum of 2 quarters · filed 2023-05-11 | -$58.98M derived: sum of 3 quarters · filed 2023-05-11 | -$79.46M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$30.24M derived: sum of 2 quarters · filed 2023-03-14 | -$50.73M derived: sum of 3 quarters · filed 2023-03-14 | -$72.76M 10-K · filed 2023-03-14 | -$73.19M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | -$22.55M 10-Q · filed 2022-11-10 | -$43.03M derived: sum of 2 quarters · filed 2022-11-10 | -$65.07M 10-Q · filed 2022-11-10 | -$78.28M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$20.48M 10-Q · filed 2022-08-11 | -$42.52M 10-Q · filed 2022-08-11 | -$55.73M derived: sum of 3 quarters · filed 2022-08-11 | -$64.16M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$22.03M 10-Q · filed 2022-05-12 | -$35.25M derived: sum of 2 quarters · filed 2022-05-12 | -$43.68M derived: sum of 3 quarters · filed 2022-05-12 | -$68.91M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$13.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$21.65M derived: sum of 2 quarters · filed 2022-03-10 | -$46.87M derived: sum of 3 quarters · filed 2022-03-10 | -$62.55M 10-K · filed 2022-03-10 | -$62.55M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | -$8.43M 10-Q · filed 2021-11-10 | -$8.43M 10-Q · filed 2020-11-05 | -$33.66M derived: sum of 2 quarters · filed 2021-11-10 | -$49.34M 10-Q · filed 2021-11-10 | -$49.34M 10-Q · filed 2020-11-05 | -$54.78M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | -$25.23M 10-Q · filed 2021-08-11 | -$25.23M 10-Q · filed 2020-08-06 | -$40.91M 10-Q · filed 2021-08-11 | -$40.91M 10-Q · filed 2020-08-06 | -$46.35M derived: sum of 3 quarters · filed 2021-08-11 | -$57.25M derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | -$15.68M 10-Q · filed 2021-05-11 | -$15.68M 10-Q · filed 2020-05-07 | -$21.12M derived: sum of 2 quarters · filed 2021-05-11 | -$32.03M derived: sum of 3 quarters · filed 2021-05-11 | -$53.26M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | -$5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$16.35M derived: sum of 2 quarters · filed 2021-03-11 | -$37.58M derived: sum of 3 quarters · filed 2021-03-11 | -$58.27M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$10.91M 10-Q · filed 2020-11-05 | -$32.13M derived: sum of 2 quarters · filed 2020-11-05 | -$52.82M 10-Q · filed 2020-11-05 | -$72.97M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$21.23M 10-Q · filed 2020-08-06 | -$41.92M 10-Q · filed 2020-08-06 | -$62.07M derived: sum of 3 quarters · filed 2020-08-06 | -$76.80M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$20.69M 10-Q · filed 2020-05-07 | -$40.84M derived: sum of 2 quarters · filed 2020-05-07 | -$55.58M derived: sum of 3 quarters · filed 2020-05-07 | -$80.75M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$34.89M derived: sum of 2 quarters · filed 2020-03-11 | -$60.05M derived: sum of 3 quarters · filed 2020-03-11 | -$78.10M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$14.74M 10-Q · filed 2019-11-07 | -$39.91M derived: sum of 2 quarters · filed 2019-11-07 | -$57.96M 10-Q · filed 2019-11-07 | -$66.32M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$25.17M 10-Q · filed 2019-08-07 | -$43.22M 10-Q · filed 2019-08-07 | -$51.58M derived: sum of 3 quarters · filed 2019-08-07 | -$60.35M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$18.05M 10-Q · filed 2019-05-14 | -$26.41M derived: sum of 2 quarters · filed 2019-05-14 | -$35.18M derived: sum of 3 quarters · filed 2019-05-14 | -$42.76M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$8.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$17.13M derived: sum of 2 quarters · filed 2019-03-26 | -$24.71M derived: sum of 3 quarters · filed 2019-03-26 | -$31.68M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | -$8.76M 10-Q · filed 2018-11-08 | -$16.35M derived: sum of 2 quarters · filed 2018-11-08 | -$23.32M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$7.59M 10-Q · filed 2018-08-08 | -$14.56M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |